Dow Jones with strongest monthly profit since 1987


Novavax is still a bit away from course records, unlike corporations such as Moderna, Biontech or Curevac. Their shares were on Monday with price jumps between 13 percent and 22.3 percent more expensive than ever. Moderna had announced that approval for a corona vaccine in the EU should also be applied for this Monday. At Biontech there is speculation about a very quick approval in Great Britain.


Aside from the coronavirus situation, the prospect of takeovers heated tempers. S&P Global plans to take over competitor IHS Markit in a $ 44 billion share deal. While the Markit titles gained 7.5 percent, those of S&P Global brought it to a plus of 3.1 percent.

Another topic of conversation is a possible Salesforce bid for Slack. An increase of 5.5 percent catapulted them over the previous record of 42 dollars, which came from the day of the IPO in June 2019. As the business broadcaster CNBC reported, citing circles, an offer could come on Tuesday. Salesforce shares fell 0.8 percent to their lowest level since early November.

Source link


Please enter your comment!
Please enter your name here